Taxonomic update on proposed nomenclature and classification changes for bacteria of medical importance, 2015

Janda, J. Michael

doi:10.1016/j.diagmicrobio.2016.06.021

Cited by 10 publications

(5 citation statements)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Table 2 shows how Gram-negative enteric bacteria can be grouped according to clinical and infection control relevance. 48,101,117,118 In most laboratories, the detail and level of identification of bacteria will be dependent also on the technical and economic feasibility of the identification system used.…”

Section: Clinical Decision Makingmentioning

confidence: 99%

Clinical bacteriology in low-resource settings: today's solutions

Ombelet

Ronat

Walsh

et al. 2018

The Lancet Infectious Diseases

140

159

View full text Add to dashboard Cite

Low-resource settings are disproportionately burdened by infectious diseases and antimicrobial resistance. Good quality clinical bacteriology through a well functioning reference laboratory network is necessary for effective resistance control, but low-resource settings face infrastructural, technical, and behavioural challenges in the implementation of clinical bacteriology. In this Personal View, we explore what constitutes successful implementation of clinical bacteriology in low-resource settings and describe a framework for implementation that is suitable for general referral hospitals in low-income and middle-income countries with a moderate infrastructure. Most microbiological techniques and equipment are not developed for the specific needs of such settings. Pending the arrival of a new generation diagnostics for these settings, we suggest focus on improving, adapting, and implementing conventional, culture-based techniques. Priorities in low-resource settings include harmonised, quality assured, and tropicalised equipment, consumables, and techniques, and rationalised bacterial identification and testing for antimicrobial resistance. Diagnostics should be integrated into clinical care and patient management; clinically relevant specimens must be appropriately selected and prioritised. Open-access training materials and information management tools should be developed. Also important is the need for onsite validation and field adoption of diagnostics in low-resource settings, with considerable shortening of the time between development and implementation of diagnostics. We argue that the implementation of clinical bacteriology in low-resource settings improves patient management, provides valuable surveillance for local antibiotic treatment guidelines and national policies, and supports containment of antimicrobial resistance and the prevention and control of hospital-acquired infections.

show abstract

Section: Clinical Decision Makingmentioning

confidence: 99%

Clinical bacteriology in low-resource settings: today's solutions

Ombelet

Ronat

Walsh

et al. 2018

The Lancet Infectious Diseases

140

159

View full text Add to dashboard Cite

show abstract

“…In summary, communication of prokaryotic taxonomic changes (in clinically relevant fashion) to our clinical colleagues may tremendously impact the care of patients. While published resources, such as Journal of Clinical Microbiology and other compendia (3,(16)(17)(18)(19)(20)(21)(22)(23), have sought to provide such updates, additional on-line resources can be of assistance. One such service, LPSN (List of Prokaryotic Names with Standing in Nomenclature) (bacterio.net), does provide notations of whether a given taxonomic designation has been "validly" or "nonvalidly" named.…”

Section: Discussionmentioning

confidence: 99%

Summary of Novel Bacterial Isolates Derived from Human Clinical Specimens and Nomenclature Revisions Published in 2018 and 2019

Munson

Carroll

2021

J Clin Microbiol

View full text Add to dashboard Cite

Knowledge of novel prokaryotic taxa discovery and nomenclature revisions is of importance to clinical microbiology laboratory practice, infectious disease epidemiology, and studies of microbial pathogenesis. Relative to bacterial isolates derived from human clinical specimens, we present an in-depth summary of novel taxonomic designations and revisions to prokaryotic taxonomy that were published in 2018 and 2019. Included are several changes pertinent to former designations of or within Propionibacterium spp., Corynebacterium spp., Clostridium spp., Mycoplasma spp., Methylobacterium spp., and Enterobacteriaceae. Future efforts to ascertain clinical relevance for many of these changes may be augmented by a Document Development Committee that has been appointed by the Clinical and Laboratory Standards Institute.

show abstract

“…list [9] as a starting point, and added year of description for each species, removed not validly described species (i.e. those not recognized by the ICNP) and checked for name changes using the ‘List of Prokaryotic names with Standing in Nomenclature’ (LPSN) (https://lpsn.dsmz.de/; accessed June–November 2021) [15], as well as taxonomic updates published in [17–24] (). Three papers published by Munson and Carroll [17–19] compile new bacterial species associated with humans described in the years 2012 to 2019, from which all species meeting our definitions were taken ().…”

Section: Methodsmentioning

confidence: 99%

“…We took the Taylor et al list [9] as a starting point, and added year of description for each species, removed not validly described species (i.e. those not recognized by the ICNP) and checked for name changes using the 'List of Prokaryotic names with Standing in Nomenclature' (LPSN) (https://lpsn.dsmz.de/; accessed June-November 2021) [15], as well as taxonomic updates published in [17][18][19][20][21][22][23][24] (Fig. 1a).…”

Section: Search Strategymentioning

confidence: 99%

A comprehensive list of bacterial pathogens infecting humans

et al. 2022

View full text Add to dashboard Cite

There exists an enormous diversity of bacteria capable of human infection, but no up-to-date, publicly accessible list is available. Combining a pragmatic definition of pathogenicity with an extensive search strategy, we report 1513 bacterial pathogens known to infect humans described pre-2021. Of these, 73 % were regarded as established (have infected at least three persons in three or more references) and 27 % as putative (fewer than three known cases). Pathogen species belong to 10 phyla and 24 classes scattered throughout the bacterial phylogeny. We show that new human pathogens are discovered at a rapid rate. Finally, we discuss how our results could be expanded to a database, which could provide a useful resource for microbiologists. Our list is freely available and archived on GitHub and Zenodo and we have provided walkthroughs to facilitate access and use.

show abstract

Taxonomic update on proposed nomenclature and classification changes for bacteria of medical importance, 2015

Cited by 10 publications

References 49 publications

Clinical bacteriology in low-resource settings: today's solutions

Clinical bacteriology in low-resource settings: today's solutions

Summary of Novel Bacterial Isolates Derived from Human Clinical Specimens and Nomenclature Revisions Published in 2018 and 2019

A comprehensive list of bacterial pathogens infecting humans

Contact Info

Product

Resources

About